Glanbia appoints Wendy Chang Smith as CFO Designate
She succeeds Mark Garvey who retires in March 2027 after 13 years leading the finance function and board governance.
See the latest news and media coverage for Glanbia. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nutrition products and ingredients company
glanbia.comLast updated
In short: Glanbia reported strong earnings growth, raised its profit outlook amid high protein demand, and announced CFO Mark Garvey's retirement.
She succeeds Mark Garvey who retires in March 2027 after 13 years leading the finance function and board governance.
Leaders outline group ambitions, segment performance, and financial targets for 2026 to 2028 across nutrition portfolios.
Adjusted EPS rose 30% to 81.24 cents, revenue reached $2.1 billion, and FY26 EPS growth guidance was raised to 17-20%.
The company achieved validation of updated Scope 3 targets by SBTi, including FLAG emissions.
The nutrition and ingredients specialist has announced a CFO designate as its current financial lead sets departure date.
Glanbia has reported that it has managed to get a handle on the increased whey costs that eroded 2025's performance.
The growing demand for weight-loss drugs globally is proving a boon for Glanbia. The Kilkenny-based nutrition group reported a 7 per cent jump in revenue...
Nutrition supplement maker Glanbia hiked its full-year profit forecast on Thursday following bumper demand for its protein products, including from customers using them in tandem...
Track Glanbia and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Glanbia and other trending companies.